• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防性隔离灌注作为肢体侵袭性恶性黑色素瘤的主要治疗方法。

Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.

作者信息

McBride C M, Sugarbaker E V, Hickey R C

出版信息

Ann Surg. 1975 Sep;182(3):316-24. doi: 10.1097/00000658-197509000-00014.

DOI:10.1097/00000658-197509000-00014
PMID:1164059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1343946/
Abstract

The most common causes of treatment failure in patients with malignant melanoma treated by surgical therapy alone are local or regional recurrences. These are presumed to be due to occult metastasis present at the time of the initial treatment. In an effort to control this occult regional disease, 202 patients with Stage I malignant melanoma underwent isolation-perfusion with 1-phenylalanine mustard between the years 1960 and 1970. The 2-5 and 10-year determinate survival rates were 98%, 86% and 83%, respectively. In these patients, 2% developed local recurrences, 3% developed intransit metastasis, 18% developed positive regional lymph nodes and 6% developed disseminated disease, as their first evidence of recurrence. Over 40% of these patients were benefitted by further therapy. When regional perfusion is used, the question of prophylactic lymph node dissection need not arise. There was one surgical death in this series and only a few patients had symptomatology referable to their limbs beyond 3 months.

摘要

仅接受手术治疗的恶性黑色素瘤患者治疗失败的最常见原因是局部或区域复发。这些复发被认为是由于初始治疗时存在隐匿性转移。为了控制这种隐匿性区域疾病,1960年至1970年间,202例I期恶性黑色素瘤患者接受了苯丙氨酸氮芥隔离灌注治疗。2年、5年和10年的确定生存率分别为98%、86%和83%。在这些患者中,2%出现局部复发,3%出现途中转移,18%出现区域淋巴结阳性,6%出现播散性疾病,作为复发的首个证据。超过40%的这些患者从进一步治疗中受益。当采用区域灌注时,不必考虑预防性淋巴结清扫问题。该系列中有1例手术死亡,只有少数患者在3个月后出现与肢体相关的症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db6/1343946/ef68ee98e0b2/annsurg00283-0157-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db6/1343946/ef68ee98e0b2/annsurg00283-0157-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db6/1343946/ef68ee98e0b2/annsurg00283-0157-a.jpg

相似文献

1
Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.预防性隔离灌注作为肢体侵袭性恶性黑色素瘤的主要治疗方法。
Ann Surg. 1975 Sep;182(3):316-24. doi: 10.1097/00000658-197509000-00014.
2
Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities.肢体侵袭性I期黑色素瘤隔离灌注后的生存情况及区域疾病控制
Cancer. 1976 Jan;37(1):188-98. doi: 10.1002/1097-0142(197601)37:1<188::aid-cncr2820370127>3.0.co;2-s.
3
Regional chemotherapy for melanoma. A 35-year experience.
Ann Surg. 1994 Oct;220(4):520-34; discussion 534-5. doi: 10.1097/00000658-199410000-00010.
4
[Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].[对厚度超过1.5毫米的I期黑色素瘤患者肢体进行辅助性区域隔离灌注]
Ned Tijdschr Geneeskd. 1990 Oct 20;134(42):2042-7.
5
Isolation perfusion. An adjunct to surgical excision in the primary treatment of melanoma of the extremities.隔离灌注。肢体黑色素瘤主要治疗中手术切除的辅助手段。
Am J Surg. 1971 May;121(5):583-5. doi: 10.1016/0002-9610(71)90145-0.
6
Survival after regional perfusion for limb melanoma.肢体黑色素瘤区域灌注后的生存率。
Aust N Z J Surg. 1975 Feb;45(1):32-6. doi: 10.1111/j.1445-2197.1975.tb05719.x.
7
Isolated limb perfusion with melphalan in the treatment of malignant melanoma.美法仑隔离肢体灌注治疗恶性黑色素瘤。
Br J Surg. 1980 Sep;67(9):660-2. doi: 10.1002/bjs.1800670919.
8
[Regional chemotherapy--perfusion of the extremities].[区域化疗——肢体灌注]
Kongressbd Dtsch Ges Chir Kongr. 2001;118:200-4.
9
Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.局限性高危肢体黑色素瘤的预防性孤立肢体灌注:一项多中心随机III期试验的结果。欧洲癌症研究与治疗组织恶性黑色素瘤协作组方案18832、世界卫生组织黑色素瘤项目试验15以及北美灌注组西南肿瘤协作组-8593。
J Clin Oncol. 1998 Sep;16(9):2906-12. doi: 10.1200/JCO.1998.16.9.2906.
10
Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.美法仑辅助性区域隔离灌注治疗肢体克拉克V级黑色素瘤患者。
J Surg Oncol. 1993 Apr;52(4):249-54. doi: 10.1002/jso.2930520411.

引用本文的文献

1
Primary Melanoma: from History to Actual Debates.原发性黑素瘤:从历史到当前的争议。
Curr Oncol Rep. 2019 Dec 19;21(12):112. doi: 10.1007/s11912-019-0843-x.
2
Surgery of primary melanomas.原发性黑素瘤的外科手术治疗。
Cancers (Basel). 2010 May 11;2(2):824-41. doi: 10.3390/cancers2020824.
3
Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.肢体软组织肉瘤、途中转移瘤及其他不可切除肿瘤的隔离肢体灌注:优点、缺点及未来展望

本文引用的文献

1
Malignant melanoma; ten-year results following excision and regional gland resection.恶性黑色素瘤;切除及区域淋巴结切除后的十年结果
Ann Surg. 1955 Jun;141(6):901-9. doi: 10.1097/00000658-195506000-00015.
2
MELANOMA OF THE EXTREMITIES; EXPERIENCES WITH CONVENTIONAL TREATMENT AND PERFUSION IN 339 CASES.肢体黑色素瘤;339例常规治疗及灌注治疗经验
Am J Surg. 1965 Sep;110:366-83. doi: 10.1016/0002-9610(65)90076-0.
3
MALIGNANT MELANOMA: A CLINICAL STUDY OF 427 CASES.恶性黑色素瘤:427例临床研究。
Curr Oncol Rep. 2001 Jul;3(4):359-67. doi: 10.1007/s11912-001-0090-8.
4
The treatment of state I melanoma of the extremities with regional hyperthermic isolation perfusion.肢体I期黑色素瘤的区域热灌注隔离治疗。
Ann Surg. 1982 Sep;196(3):316-23. doi: 10.1097/00000658-198209000-00010.
5
Isolated regional perfusion; anaesthetic technique, monitoring and blood replacement.孤立性区域灌注;麻醉技术、监测与血液置换
Can Anaesth Soc J. 1984 Sep;31(5):552-8. doi: 10.1007/BF03009542.
6
Pelvic perfusion hyperthermia for advanced pelvic malignancies.晚期盆腔恶性肿瘤的盆腔灌注热疗
Jpn J Surg. 1985 Jan;15(1):49-54. doi: 10.1007/BF02469857.
7
Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding.腹腔热灌注联合手术对伴有腹膜种植的胃癌患者有效。
Ann Surg. 1988 Jul;208(1):36-41. doi: 10.1097/00000658-198807000-00005.
8
Hyperthermic perfusion with chemotherapy for melanoma of the extremities.肢体黑色素瘤的热灌注化疗
World J Surg. 1989 Sep-Oct;13(5):598-602. doi: 10.1007/BF01658878.
9
Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study.269例原发性皮肤黑色素瘤患者的治疗结果:一项为期五年的前瞻性研究。
Ann Surg. 1977 Aug;186(2):201-9. doi: 10.1097/00000658-197708000-00013.
10
Combined modality therapy of malignant melanoma.恶性黑色素瘤的综合治疗
World J Surg. 1979 Jul 30;3(3):329-43. doi: 10.1007/BF01556586.
Ann Surg. 1965 Jul;162(1):15-28. doi: 10.1097/00000658-196507000-00003.
4
RESULTS OF GROIN DISSECTION FOR MALIGNANT MELANOMA IN 220 PATIENTS.220例恶性黑色素瘤患者腹股沟淋巴结清扫结果
Surgery. 1964 Apr;55:485-94.
5
The role of regional node dissection in the treatment of malignant melanoma.
Arch Surg. 1962 Jul;85:63-9. doi: 10.1001/archsurg.1962.01310010067009.
6
A clinical study of 250 patients with malignant melanoma.一项针对250例恶性黑色素瘤患者的临床研究。
Surg Gynecol Obstet. 1962 Sep;115:333-41.
7
Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults.117例成人皮肤恶性黑色素瘤的临床病理相关性研究
Cancer. 1958 Sep-Oct;11(5):1025-43. doi: 10.1002/1097-0142(195809/10)11:5<1025::aid-cncr2820110525>3.0.co;2-3.
8
Treatment of malignant neoplasms with chemotherapeutic agents utilizing a pump-oxygenator: technics and early results.
Bull Tulane Univ Med Fac. 1958 Feb;17(2):133-43.
9
Prognostic significance of lymph node dissection in the treatment of malignant melanoma.淋巴结清扫术在恶性黑色素瘤治疗中的预后意义
Cancer. 1970 Sep;26(3):606-9. doi: 10.1002/1097-0142(197009)26:3<606::aid-cncr2820260317>3.0.co;2-m.
10
The malignant melanoma of the skin. New theories based on a study of 500 cases.皮肤恶性黑色素瘤。基于500例病例研究的新理论。
Acta Chir Scand Suppl. 1966;365:1-222.